CiVi Biopharma is a clinical-stage research and development biotechnology company. It focuses on creating therapies for cardiovascular, metabolic, and related diseases. CiVi Biopharma's pipeline includes CiVi007, a molecule developed for the treatment of hypercholesterolemia and the prevention of cardiovascular disease. In addition, it has other clinical-stage development program activities aimed at treating severe liver diseases.
|HQ||Chevy Chase, MD, US||Map|
|Employees (est.) (Sept 2021)||17|
CiVi Biopharma total Funding
CiVi Biopharma latest funding size
Time since last funding
|3 years ago|
CiVi Biopharma investors
When was CiVi Biopharma founded?
CiVi Biopharma was founded in 2016.
Who are CiVi Biopharma key executives?
CiVi Biopharma's key executives are Shal Jacobovitz, Henrik Ørum and Chuck Shear.
How many employees does CiVi Biopharma have?
CiVi Biopharma has 17 employees.
Who are CiVi Biopharma competitors?
Competitors of CiVi Biopharma include Amarillo Biosciences, Experimur and Patient Choice Laboratories.
Where is CiVi Biopharma headquarters?
CiVi Biopharma headquarters is located at 5425 Wisconsin Ave 6th floor, Chevy Chase.
Where are CiVi Biopharma offices?
CiVi Biopharma has offices in Chevy Chase and Conshohocken.
How many offices does CiVi Biopharma have?
CiVi Biopharma has 2 offices.
Receive alerts for 300+ data fields across thousands of companies